Author's Reply to: Osimertinib and jaw osteonecrosis? A case report
Int J Cancer
.
2019 Oct 1;145(7):2006-2007.
doi: 10.1002/ijc.32398.
Epub 2019 May 10.
Authors
Lilan Yi
1
,
Peng Luo
1
,
Jian Zhang
1
Affiliation
1
Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
PMID:
31074838
DOI:
10.1002/ijc.32398
No abstract available
Publication types
Letter
Comment
MeSH terms
Acrylamides
Aniline Compounds
ErbB Receptors
Humans
Jaw Diseases*
Osteonecrosis*
Substances
Acrylamides
Aniline Compounds
osimertinib
EGFR protein, human
ErbB Receptors